Sanofi-aventis and Sunnybrook Health Sciences Centre to Develop Treatment for Diabetic Foot Ulcers

Sanofi-aventis SNY and Sunnybrook Health Sciences Centre (Toronto, Canada) announced that they have entered into a research agreement and licensing option for vasculotide, an investigational compound to treat chronic wounds. This includes neuropathic diabetic foot ulcers caused by a lack of sensation and neuropathic ulcers that are complicated by peripheral arterial disease, commonly called neuroischemic diabetic foot ulcers.